Literature DB >> 15749389

Beryllium-stimulated reactive oxygen species and macrophage apoptosis.

Richard T Sawyer1, David R Dobis, Mark Goldstein, Leonard Velsor, Lisa A Maier, Andrew P Fontenot, Lori Silveira, Lee S Newman, Brian J Day.   

Abstract

Beryllium (Be), the etiologic agent of chronic beryllium disease, is a toxic metal that induces apoptosis in human alveolar macrophages. We tested the hypothesis that Be stimulates the formation of reactive oxygen species (ROS) which plays a role in Be-induced macrophage apoptosis. Mouse macrophages were exposed to 100 microM BeSO4 in the absence and presence of the catalytic antioxidant MnTBAP (100 microM). Apoptosis was measured as the percentage of TUNEL+ and caspase-8+ cells. ROS production was measured by flow cytometry using the fluorescence probes, dihydroethidine (DHE) and dichlorofluorescein diacetate (DCFH-DA). Be-exposed macrophages had increased TUNEL+ cells (15+/-1% versus controls 1+/-0.2%, P<0.05) and increased caspase-8+ cells (18.7+/-2% versus controls 1.8+/-0.4%, P<0.05). Be-induced caspase-8 activation, and a 4-fold increase in ROS formation, was ameliorated by exposure to MnTBAP. Hydrogen peroxide (30 microM) exposure potentiated Be-induced caspase-8 activation, and was also attenuated by MnTBAP. Our data are the first to demonstrate that Be stimulates macrophage ROS formation which plays an important role in Be-induced macrophage apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749389     DOI: 10.1016/j.freeradbiomed.2004.12.014

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

2.  Biological exposure metrics of beryllium-exposed dental technicians.

Authors:  Moshe Stark; Yehuda Lerman; Arik Kapel; Asher Pardo; Yehuda Schwarz; Lee Newman; Lisa Maier; Elizabeth Fireman
Journal:  Arch Environ Occup Health       Date:  2014       Impact factor: 1.663

Review 3.  Immunologic Effects of Beryllium Exposure.

Authors:  Andrew P Fontenot
Journal:  Ann Am Thorac Soc       Date:  2018-04

Review 4.  Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.

Authors:  Andrew P Fontenot; Michael T Falta; John W Kappler; Shaodong Dai; Amy S McKee
Journal:  J Immunol       Date:  2016-01-01       Impact factor: 5.422

5.  Immunotoxicology of beryllium lung disease.

Authors:  Lee S Newman
Journal:  Environ Health Prev Med       Date:  2007-07       Impact factor: 3.674

Review 6.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

7.  Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages.

Authors:  Bi-Hua Cheng; Yunlong Liu; Xiaoling Xuei; Chung-Ping Liao; Debao Lu; Mark E Lasbury; Pamela J Durant; Chao-Hung Lee
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

8.  The uses and adverse effects of beryllium on health.

Authors:  Ross G Cooper; Adrian P Harrison
Journal:  Indian J Occup Environ Med       Date:  2009-08

9.  Deoxycholate, an endogenous cytotoxin/genotoxin, induces the autophagic stress-survival pathway: implications for colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Hana Holubec; Katerina Dvorak; Carol Bernstein; Mary Pat Moyer; Harinder Garewal; Harris Bernstein
Journal:  J Toxicol       Date:  2009-05-10

10.  Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease.

Authors:  Dave R Dobis; Richard T Sawyer; May M Gillespie; Jie Huang; Lee S Newman; Lisa A Maier; Brian J Day
Journal:  Am J Respir Crit Care Med       Date:  2008-01-24       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.